Home > Press > Industrial Nanotech, Inc. Completing Final Stages of Audit Process
Abstract:
Industrial Nanotech (Pink Sheets:INTK), developers of revolutionary products that incorporate the science of nanotechnology, today announced that it is completing the final stages of its audit process.
J.R. Lampson, hired as VP of Finance for Industrial Nanotech, Inc. in November of 2006 states, "Our team of CPAs has worked closely with us to conduct a thorough, detailed, and exhaustive analysis of our Company financials since inception in 2004, to review and revise as necessary all policies and procedures relating to Company operations worldwide, and to draft the Financial Procedures Manual and other documents required by our auditors and the regulatory agencies of stock exchanges which our Company considers an important objective."
Stuart Burchill, CEO of Industrial Nanotech, Inc. continues, "The facts about our Company are solid. We have a respectable and healthy rate of revenue growth since inception. We have, and have communicated to the investing public through press releases, very large projects and substantial potential revenue sources in the pipeline and at a mature stage of development. We continue to invent new and important technologies and product lines and file patent applications to protect our intellectual property. Our expansion worldwide is striding forward country by country and we have an established record of entering markets, establishing credibility in those markets, and increasing the revenue from those markets."
"This relentless work ethic and the successes it is generating make it a priority for us to position the Company to be able to reach a broader audience of potential shareholders, brokerage firms, and institutional investors," states Mr. Burchill. "Completion of the work by Mr. Lampson, our new VP of Finance with decades of experience at the highest levels of financial operations of major international corporations, combined with the substantial resources and expertise of our accounting firm, puts us in the position to move forward towards that objective in a timely manner."
####
About Industrial Nanotech, Inc.
Industrial Nanotech Inc. is quickly emerging as a global nanoscience solutions and research leader. The Company develops and commercializes new and innovative applications for nanotechnology. Additional information about the Company and its products can be found at their websites, ( http://www.industrial-nanotech.com ) and ( http://www.nansulate.com ).
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic and business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
For more information, please click here
Contacts:
For Industrial Nanotech Inc., Naples
Investor Relations:
Martin E. Janis & Company, Inc.
Beverly Jedynak, President, 312-943-1100 ext. 12
or
Media Inquiries:
Martin E. Janis & Company, Inc.
Laura Grock, Vice President, 312-943-1100 ext. 13
Copyright © Business Wire
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||